LifeMD Q1 Revenue Hits $50.2M with 88% Margin and 42,000 Subscriber Net Adds
LifeMD generated $50.2M revenue in Q1 2026, matching guidance, with an 88% gross margin up 420bps year-over-year and an adjusted EBITDA loss of $4.5M. The company added 42,000 net telehealth subscribers, exited with $34.5M cash, no debt, and affirmed full-year guidance of $220–230M revenue and $12–17M adjusted EBITDA.
1. Q1 Financial Performance
LifeMD reported Q1 revenue of $50.2 million, slightly below last year’s $50.9 million, with an 88% gross margin up from 84% a year earlier. Adjusted EBITDA loss widened to $4.5 million following increased marketing investments, while GAAP net loss was $9.6 million or $0.20 per share.
2. Subscriber Growth
The company added a record 42,000 net telehealth subscribers, lifting total active subscribers to over 365,000, a 26% year-over-year increase. Weight management program sign-ups grew approximately 120% sequentially, and women’s health patient sign-ups surged 657%, with customer acquisition costs down 70%.
3. Balance Sheet and Guidance
LifeMD ended the quarter with $34.5 million in cash, no debt, and a $30 million undrawn credit facility. Management reaffirmed full-year 2026 guidance of $220–230 million revenue and $12–17 million adjusted EBITDA, anticipating annualized run-rate revenue to exceed $250 million and EBITDA $25 million by Q4.